Observational studyActa oncologica (Stockholm, Sweden)2026

FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.

Aija Knuuttila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.